Incyte is a global biopharmaceutical company focused on finding innovative solutions for serious unmet medical needs through the discovery, development and commercialization of novel …

Incyte supports significant independent research aimed at enhancing disease understanding and advancing the study of our products by generating health outcomes data and real-world …

Incyte is a global biopharmaceutical company that has created a robust and diversified portfolio of marketed products and clinical candidates in oncology and inflammation and autoimmunity.

Lee Heeson joined Incyte in October of 2024 as Executive Vice President and Head of Incyte International. In his role, Mr. Heeson will lead commercial activities for Incyte outside of the …

Incyte’s team of biologists and chemists are pursuing new areas in drug discovery and development in order to help patients.

Incyte is focused delivering medicines that may offer patients with cancer new options in treatment by addressing tumors from multiple directions with targeted and immunotherapies.

Please be aware that these offers and communications are not legitimate and are not authorized by Incyte. Incyte only hires for job postings that appear on this website.

Learn about Incyte’s inspiring and inclusive environment where employees grow and thrive and are supported in reaching their full potential.

Find directions to Incyte corporation’s Wilmington Delaware headquarters and European headquarters in Geneva Switzerland. Visit Incyte.com for more information. Also find links to …

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can …